Skip to main content
Log in

DNA patenting: the end of an era?

  • Patents
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Debates on patenting DNA must evolve to reflect the global decline in filings and regional disparities in patenting activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

References

  1. Heller M.A. & Eisenberg R.S. Science 280, 698–701 (1998).

    Article  CAS  Google Scholar 

  2. Matthijs, G. BMJ 329, 1358–1360 (2004).

    Article  Google Scholar 

  3. Nuffield Council on Bioethics. The ethics of patenting DNA: a discussion paper (Nuffield Council, London, 2002). <http://www.nuffieldbioethics.org/publications/pp_0000000014.asp>

  4. Merz J.F. et al. Nature 415, 577–579 (2002).

    Article  CAS  Google Scholar 

  5. National Academy of Sciences. Reaping the benefits of genomic and proteomic research: intellectual property rights, innovation and public health (National Academies Press, Washington, DC, 2005) <http://www.nap.edu/catalog/11487.html>

  6. Hansen, S. et al. Intellectual property in the AAAS scientific community (AAAS, Washington, DC, 2005).

  7. Stern, S. & Murray, F.E. Do formal intellectual property rights hinder the free flow of scientific knowledge? An empirical test of the anti-commons hypothesis. National Bureau of Economic Research Working Paper No. W11465 (July 2005). <http://ssrn.com/abstract=755701>

  8. Walsh J.P. et al. in Patents in the knowledge-based economy (eds. Cohen W.N. & Merrill S.) pp. 285–340 (National Academy Press, Washington, DC, 2003).

    Google Scholar 

  9. Thomas S.M. et al. Nat. Biotechnol. 20, 1185–1188 (2002).

    Article  CAS  Google Scholar 

  10. Biotechnology Innovation Report 2004: Benchmarks (Finnegan, Henderson Farabow Garret and Dunner, Washington, DC, 2004).

  11. Jensen, K. & Murray, F. Science 310, 239–240 (2005).

    Article  CAS  Google Scholar 

  12. Pressman, L. et al. Nat. Biotechnol. 24, 31–39 (2006).

    Article  CAS  Google Scholar 

  13. Trilateral Statistical Report 2004 Edition (EPO, JPO, and USPTO with cooperation of WIPO; Munich, October 2005) <http://www.trilateral.net/tsr/tsr_2004/tsr2004.pdf>

  14. <http://ep.espacenet.com/advancedSearch?locale=en_EP>

  15. FR Doc 01-322, Federal Register 66, No. 4 (January 2001). <http://www.uspto.gov/web/offices/com/sol/notices/utilexmguide.pdf>

  16. Cost analysis data produced by the EPO available at http://www.european-patent-office.org/epo/new/cost_analysis_2005_en.pdf

  17. Hopkins, M.M. et al. The Patenting of Human DNA: Global Trends in Public and Private Sector Activity (A report for the European Commission, compiled by SPRU, Brighton, UK, November 2006). <http:www.sussex.ac.uk/spru/documents/patgen_finalreport.pdf>

    Google Scholar 

  18. <http://www.trilateral.net/projects/biotechnology/reach_through_claims/>

Download references

Acknowledgements

This research was funded by the European Commission's 6th Framework program. The authors are grateful for the generous time given by our interviewees; the project advisory committee, Robert Wells, Siobhán Yeats, Joseph Straus; as well as to Alma Rocha, Alex Bousios, Ryosuke Ohashi and Rachel Thornley, and Thomson Scientific for technical assistance. The conclusions drawn are those of the authors' alone.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hopkins, M., Mahdi, S., Patel, P. et al. DNA patenting: the end of an era?. Nat Biotechnol 25, 185–187 (2007). https://doi.org/10.1038/nbt0207-185

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0207-185

  • Springer Nature America, Inc.

This article is cited by

Navigation